E-Mail
IMAGE: The Hackensack Meridian Health scientists and clinicians continue to study the promise and potential of convalescent plasma for COVID-19 treatment. view more
Credit: Hackensack Meridian Health
March 10, 2021 - Hackensack, NJ - Convalescent plasma, the use of survivors antibodies transfused into sick COVID-19 patients is safe and significantly improves clinical outcomes when using high levels of antibodies, according to a new publication by scientists at Hackensack Meridian Health, New Jersey s largest and most comprehensive health network.
The treatment was safe, transferred the survivors antibodies, and did not prevent the recipients from making their own antibodies, according to the results published recently in the journal
Vaccines being administered across Ocean and Monmouth Counties
Published: December 31, 2020
Covid-19 vaccine administered in Ocean County as Freeholder Gary Quinn and Health Coordinator Dan Regenye look on. (Donna Flynn, Ocean County Government)
We re in the first round of vaccinations from Pfizer and Moderna being administered to Healthcare and frontline workers and those in long term care facilities.
As the vaccines have arrived at the Jersey Shore, hospitals and health leaders have overseen the process take place in Ocean and Monmouth Counties.
Ocean County began distributing its first 1,500 doses of the COVID 19 vaccine from Moderna to health care workers at a vaccination clinic this week set up at the RWJ Barnabas Health Arena on the campus of Toms River High School North.
Drive to get people to participate in Johnson & Johnson coronavirus vaccine trial kicks off at N.J. hospital
Updated Dec 30, 2020;
Posted Dec 29, 2020
Drug trial participant receives an injection from Abimbola Coker, RN. Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 COVID-19 vaccine trial named ENSEMBLE 2, at the Jersey Shore University Medical Center. in Neptune, N.J. December, 29, 2020
Yellow tape is placed on the syringe so participants cannot tell if they receive the drug or the placebo.
Ed Murray | NJ Advance Media for
Facebook Share
A recruitment drive to enroll participants for Johnson & Johnson’s coronavirus virus vaccine trial kicked off Tuesday at Jersey Shore University Medical Center as the New Jersey-based company seeks to give the public another vaccination option.